Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Immunome, Inc. Financials Banner

Immunome, Inc. Financials

IMNM Stock Analysis

Page title

Section title

IMNM Income Statement Key Metrics

  • Revenue(TTM)10.78 M
  • Gross Profit(TTM)9.42 M
  • EBITDA(TTM)-270.40 M
  • Net Income(TTM)-262.59 M
  • EPS Diluted(TTM)-17.74

Decode IMNM's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

IMNM earnings and revenue history

Gross Profit Margin vs Peers

Profit margin ratio of IMNM (0.948) is higher than the average of its peers (-0.150).

Net Profit Margin vs Peers

Net profit margin ratio of IMNM (-7.619) is lower than the average of its peers (-3.232).

IMNM Return on Equity

See how efficiently IMNM generates profit for it's shareholders.

-89.09%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity vs Peers

Return on Equity ratio of IMNM (-0.891) is lower than the average of its peers (-0.144).

Return on Equity Growth

IMNM's Return on Equity has shown poor growth over the past 10 years, increasing by only -19.16%.

IMNM Revenue Growth

See how IMNM has grown it's revenue over the past 10 years.


Revenue Growth

IMNM's revenue has grown significantly over the past 10 years, increasing by over 0%.

IMNM FY, 2023 Revenue Breakdown

See how IMNM converts it's revenue into profit.

IMNM Balance Sheet Health

IMNM Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

IMNM financial position analysis

Short Term Liabilities

IMNM's short term assets($145M) can safely cover it's short term liabilities($22M).

Long Term Liabilities

IMNM's short term assets($145M) can safely cover it's long term liabilities($7M).

IMNM Debt to Equity